← All companiesBBioRestorative Therapies, Inc.
BRTX - CIK 0001505497
BioRestorative Therapies, Inc. revenue by year
BioRestorative Therapies, Inc. (BRTX) reported revenue of $359.70K for fiscal year 2025, as filed in its audited annual report with the SEC.
BRTX annual revenue
BRTX revenue 2011-2025
| Fiscal year | Revenue | Change |
|---|
| FY 2025 | $359.70K | -10.3% |
| FY 2024 | $401.00K | +175.0% |
| FY 2023 | $145.80K | +21.7% |
| FY 2022 | $119.80K | +160.4% |
| FY 2021 | $46.00K | -40.3% |
| FY 2020 | $77.00K | -40.8% |
| FY 2019 | $130.00K | +17.1% |
| FY 2018 | $111.00K | +37.0% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does BioRestorative Therapies, Inc. make?
BioRestorative Therapies, Inc. (BRTX) reported revenue of $359.70K for fiscal year 2025, as filed in its audited annual report with the SEC.
How has BioRestorative Therapies, Inc.'s revenue changed over time?
Between fiscal 2011 and fiscal 2025, BioRestorative Therapies, Inc.'s revenue grew from $0.00 to $359.70K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.